Evidence map›Paper›PMID 24795292›Full record

ReviewAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2014

Changing roles of eosinophils in health and disease.

Glenn T Furuta, F Dan Atkins, Nancy A Lee, James J Lee

Abstract readHistorical ArticleReview
In one paragraph

Review in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Roles of Immune Cells in Hereditary Angioedema.Clinical reviews in allergy & immunology · 2021
    Review
  9. Relationship between blood eosinophil levels and COVID-19 mortality.The World Allergy Organization journal · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa-induced acute lung injury and NLRP3 inflammasome activation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  16. The Role of the Environment in Eosinophilic Esophagitis.Clinical reviews in allergy & immunology · 2019
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Glenn T FurutaSection of Pediatric Gastroenterology, Hepatology and Nutrition, Digestive Health Institute, Children's Hospital Colorado, Aurora, Colorado; Gastrointestinal Eosinophilic Diseases Program, Children's Hospital Colorado, Aurora, Colorado; Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, Colorado; Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado.
F Dan AtkinsGastrointestinal Eosinophilic Diseases Program, Children's Hospital Colorado, Aurora, Colorado; Section of Allergy, Immunology, and Rheumatology, Children's Hospital Colorado, Aurora, Colorado; Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado.
Nancy A LeeDivision of Hematology and Oncology and Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona; Division of Pulmonary Medicine and Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona.
James J LeeDivision of Hematology and Oncology and Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona; Division of Pulmonary Medicine and Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona. Electronic address: jjlee@mayo.edu.

Funding

EOSINOPHIL ACTIVITIES IN MURINE MODELS OF LUNG DISEASER01HL065228 · NHLBI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI JACOBSEN, ELIZABETH A · 2000 to 2017
$6.7M
MOUSE MODELS OF EOSINOPHIL ASSOCIATED LUNG DYSFUNCTIONR01HL058723 · NHLBI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI LEE, NANCY A. · 1998 to 2013
$4.2M
Eosinophil-nerve Interactions in Mouse Models of DermatitisR01AR061567 · NIAMS · MAYO CLINIC ARIZONA · PI JACOBSEN, ELIZABETH A, JACOBY, DAVID B · 2012 to 2016
$2.9M
Patient research in eosinophilic gastrointestinal diseasesK24DK100303 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI FURUTA, GLENN T · 2013 to 2017
$889k
Mouse Models of Eosinophil-Associated Lung DysfunctionR56HL058723 · NHLBI · MAYO CLINIC ARIZONA · PI LEE, NANCY A. · 2008 to 2008
$400k
NHLBI NIH HHS R01 HL058723NHLBI NIH HHS R01HL058723NHLBI NIH HHS R01 HL065228NHLBI NIH HHS R01HL65228NHLBI NIH HHS R56 HL058723NIAMS NIH HHS R01 AR061567NIDDK NIH HHS K24 DK100303NIDDK NIH HHS K24DK100303
6 · The paper itself

Abstract

objectiveTo review and highlight the unappreciated roles of eosinophils suggested by recent studies. DATA SOURCES: The literature, unpublished observations, and insights by the authors. STUDY SELECTIONS: Basic studies of mouse models and patient-based clinical studies of disease.

resultsEosinophils are often thought of as destructive end-stage effector cells primarily linked to parasite host defense and dysregulated immune responses associated with allergic diseases, such as asthma. However, recent studies (ie, research focused on mechanisms of action and translational studies examining disease/inflammatory pathways) are suggesting far more complex roles for eosinophils. The goal of this review is 3-fold. (1) The authors examine the dynamic history of eosinophils and how physicians over time used this information to formulate defining hypotheses. Particular emphasis is placed on recent studies challenging the parochial view of host defense in favor of roles maintaining homeostasis through immune modulation and tissue remodeling/repair. (2) They discuss diagnostic approaches to assess eosinophils in clinical settings as a means of disease identification and subsequently as a measurement of disease severity. (3) They examine how contemporary views of eosinophils and their perceived roles in diseases have led to specific therapeutic strategies. The emphasis is to review the successes and failures of these strategies as the basis of formulating future clinical studies targeting eosinophils as potential therapies of disease.

conclusionDespite the complexities of eosinophil-mediated activities and the less than overwhelming success of initial attempts targeting these cells, eosinophils remain a potentially important focal target of disease diagnosis and subsequent treatment strategies.

Indexed as

AnimalsAnti-Allergic AgentsAsthmaCell MovementDermatitis, AtopicEnteritisEosinophiliaEosinophilsGastritisHistory, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHumansHypereosinophilic SyndromeInterleukin-5Leukocyte CountAnti-Allergic AgentsIL5 protein, humanInterleukin-5Receptors, Interleukin-5

Identifiers

PMID24795292
PMCPMC4065823

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.